Wed, February 12, 2025

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of IN8bio, Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Dominari Holdings Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Eos Energy Enterprises, Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Bluesky Digital Assets Corp. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Ainos, Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Treasure Global Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of DatChat, Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of BLAZO CORP in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Able View Global Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Gen 2 Technologies Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of STAAR Surgical Company in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of Cyngn Inc. in recent trading

by: WOPRAI

As of Feb 12th, 2025, there has been substantial selling of in recent trading

by: MSN

Is XRP (Ripple) a Good Buy for Less Than $3?

Sign Up For Free » However, one crypto that could be in a position to rise significantly from current levels is XRP (CRYPTO: XRP). Let's dig into why XRP could carry some enticing upside and assess if this cryptocurrency is a worthy investment as it trades for just $2.
Tue, February 11, 2025

by: Mint

Quant MF is positive on hotel, infra, and energy sectors, Sandeep Tandon says

Quant AMC said that they are shifting their focus from defensive large-cap stocks to a more aggressive style -investing in select small and mid-cap stocks.

by: MSN

Astoria's John Davi: Why the Market Is Headed for a 'Big, Fat Correction'

The next-generation portfolio advisor is a fan of diversified investing, which means he's no fan of the Magnificent Seven-heavy S&P 500.

by: MSN

What are brokers saying about CSL shares after the selloff?

The biotech giant's shares hit a 52-week low yesterday. Is this a buying opportunity? The post What are brokers saying about CSL shares after the selloff? appeared first on The Motley Fool Australia.

by: Kiplinger

Stock Market Today: Markets Reflect Elevated Uncertainty

Investors and traders as well as CEOs and central bankers continue to adjust to a new administration in Washington, D.C.

by: MSN

The Best Index ETF to Invest $1,000 in Right Now

Investing in the stock market is one of the best ways to help create wealth over the long term. However, picking individual stocks is not an easy task. In fact, only about 15% of professional fund managers have been able to outperform the S&P 500 index over the past decade.

by: MSN

Tesla, Intel lead Tuesday's market cap stock movers

Tuesday's market has seen swings in various stocks based on news and other factors. Mega-cap stocks like Tesla Motors (NASDAQ:TSLA) are experiencing significant movements, while large-cap stocks such as Fidelity National Information Services (NASDAQ:III) (FIS) are also on the move.

by: MSN

3 ways to build long-term wealth with gold as it hits a record high

Gold soars as tariffs spark concerns of a global trade war. Here's how to use gold to diversifying your portfolio and a hedge against inflation.

by: MSN

Deep value stocks are a double-digit return generator (and 6 stocks to prove it)

In this wire, Pzena Investment Management share where they find value-oriented opportunities in a mega cap-driven market.

by: MSN

The Kraft Heinz Company (KHC): Among the Best Dividend Stocks to Invest In Now According to Warren Buffett

We recently compiled a list of the 13 Best Warren Buffett Dividend Stocks To Invest In Right Now. In this article, we are going to take a look at where The Kraft Heinz Company (NASDAQ:KHC) stands against the other dividend stocks.

by: MSN

Is Exxon Mobil (XOM) the Best Widow and Orphan Stock to Invest In?

We recently published a list of 10 Best Widow and Orphan Stocks To Invest In. In this article, we are going to take a look at where Exxon Mobil Corporation (NYSE:XOM) stands against other best widow and orphan stocks to invest in.

by: MarketWatch

Stock Market Today: Dow flat while S&P 500 and Nasdaq fall with Powell testimony in focus

Follow all the latest U.S. market action for Tuesday here as investors get ready for testimony from Fed Chair Jerome Powell, a day ahead of the next inflation report.

by: tbsnews

Task force recommends no further extension for closed-end mutual funds

The task force recommended including this restriction in the upcoming Bangladesh Mutual Fund Regulations, 2025, according to the BSEC

by: MSN

These 3 REITs Have Massive Yields and Strong Growth

Real estate trusts, or REITs, offer some of the highest yields around, and for good reason. They're legally obligated to pay shareholders 90% of their earnings as dividends. But, like most things in the stock market,

by: MSN

Galecto stock hits 52-week low at $4.39 amid market challenges

Galecto Inc (GLTO) shares tumbled to a 52-week low of $4.39, reflecting a stark downturn in the biotechnology firm's market performance. According to InvestingPro data, the stock is currently trading below its Fair Value,

by: MoneyWeek

Should you continue to hold Smithson Investment Trust?

Smithson Investment Trust, a small- and mid-cap fund, has struggled to live up to lofty expectations, says Rupert Hargreaves.

by: MoneyWeek

Reeves's cash ISA raid: do cash hoarders deserve a tax break?

Rachel Reeves is desperate for her plan for economic growth to work - but meddling with the tax benefits of cash ISAs is simply a step too far, says Kalpana Fitzpatrick

by: MSN

These Top Dividend Stocks Are Investing Another $21 Billion to Support AI by 2030

Artificial intelligence (AI) has the potential to be a transformative technology. It can help improve decision-making, increase efficiency, and create more personalized experiences. These benefits are leading companies to pour billions of dollars into developing AI tools.

by: MarketWatch

Stock Market Today: Dow, S&P 500 and Nasdaq set to give back gains with Powell testimony in focus

Follow all the latest U.S. market action for Tuesday here as investors get ready for testimony from Fed Chair Jerome Powell, a day ahead of the next inflation report.

by: MSN

TFSA Investing: Best Strategies to Maximize Your 2025 Returns

Canadian investors can consider holding a diversified portfolio in a TFSA and build long-term wealth in the next decade. Let's see how. The post TFSA Investing: Best Strategies to Maximize Your 2025 Returns appeared first on The Motley Fool Canada.

by: WOPRAI

Short squeeze is starting in shares of PNTZF at $0.225, after crossing above the $0.21 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MMTIF at $0.059, after crossing above the $0.058 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LFUS at $240.06, after crossing above the $238.922 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of GLAXF at $18.53, after crossing above the $18.408 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ERIXF at $7.75, after crossing above the $7.627 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BEKE at $19.3, after crossing above the $19.282 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BABAF at $14.117, after crossing above the $13.477 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SLQT at $6.73, after crossing above the $5.876 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PLUS at $71.8, after crossing above the $70.775 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MVST at $1.745, after crossing above the $1.721 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MDV at $15.48, after crossing above the $15.292 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ABSI at $4.669, after crossing above the $4.482 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of AESI at $22.015, after crossing above the $21.854 Trigger Price

by: Newsweek

Stock Market Today: Major US Indexes Fall as Trump Imposes New Tariffs

Daniel Orton is an editor on the live news team at Newsweek, based in London, U.K. He was previously a video news editor at the company between 2017 and 2019, before spending several years as a senior video journalist on the social news team at The Wall ...

by: MSN

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

A new twist on value has investors waking up to the beauty of companies returning gobs of cash to shareholders.

What are brokers saying about CSL shares after the selloff?

The biotech giant's shares hit a 52-week low yesterday. Is this a buying opportunity? The post What are brokers saying about CSL shares after the selloff? appeared first on The Motley Fool Australia.

The article from MSN discusses the recent performance and analyst reactions to CSL shares following a significant selloff. CSL, a major player in the global biotechnology industry, experienced a sharp decline in its share price after reporting a lower-than-expected profit for the first half of the fiscal year. Despite this, several brokers have provided their insights:

  • Goldman Sachs maintained a "Buy" rating, suggesting that the selloff was an overreaction and that CSL's long-term growth prospects remain strong, particularly with its pipeline of new products.

  • UBS also recommended a "Buy," highlighting CSL's robust fundamentals and the potential for recovery as new treatments gain market approval.

  • Citi took a more cautious approach, downgrading CSL to "Neutral" due to concerns over short-term earnings pressure but acknowledged the company's solid long-term outlook.

  • Morgans kept their "Add" rating, focusing on CSL's strategic initiatives and the potential for future growth despite current challenges.

    Overall, while there is a consensus that CSL faced immediate headwinds, the general sentiment among analysts leans towards optimism about the company's future, underpinned by its innovation in treatments and a strong market position. However, investors are advised to consider both the short-term volatility and the long-term potential when making investment decisions.

    Read the Full MSN Article at:
    https://www.msn.com/en-au/money/top-stocks/what-are-brokers-saying-about-csl-shares-after-the-selloff/ar-AA1yQuMd